Distinguished in D-Plus Hemolytic Uremic Syndrome

Moglie Le Quintrec

CHU Rouen
Rouen, FR 
Distinguished in D-Plus Hemolytic Uremic Syndrome
CHU Rouen
Rouen, FR 
OverviewLocationsClinical Research

Overview

Moglie Le Quintrec practices in Rouen, France. Le Quintrec is rated as a Distinguished expert by MediFind in the treatment of D-Plus Hemolytic Uremic Syndrome. Their top areas of expertise are Membranoproliferative Glomerulonephritis, Atypical Hemolytic Uremic Syndrome (aHUS), Hemolytic-Uremic Syndrome, Kidney Transplant, and Hepato-Pancreato-Biliary Surgery.

Their clinical research consists of co-authoring 94 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 16 articles in the study of D-Plus Hemolytic Uremic Syndrome.

Locations

CHU Rouen
Rouen, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Drugs: Daprodustat, Darbepoetin Alpha
Study Phase: Phase 3
Blood Innate Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients
Blood Innate Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients
Enrollment Status: Completed
Publish Date: February 06, 2024
Intervention Type: Other
Study Phase: Not Applicable
View 1 Less Clinical Trial

94 Total Publications

Identification of Donor-recipient Interactions for a Relative Appraisal of Kidney Graft Marginality: A French Multicentric Cohort-based Study.
Identification of Donor-recipient Interactions for a Relative Appraisal of Kidney Graft Marginality: A French Multicentric Cohort-based Study.
Journal: Transplantation
Published: July 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Le Quintrec's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 30 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile